A. Horne

发表

Effects of a β-Blocker on Bone Turnover in Normal Postmenopausal Women: A Randomized Controlled Trial

I. Reid, G. Gamble, A. Grey, 2005 .

Effects of a beta-blocker on bone turnover in normal postmenopausal women: a randomized controlled trial.

I. Reid, G. Gamble, A. Grey, 2005, The Journal of clinical endocrinology and metabolism.

The Work Instability Scale Predicts Absenteeism in People With Gout and Suggests a Higher Risk for Those in Manual Occupations

W. Taylor, N. Dalbeth, A. Horne, 2012, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5‐Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open‐Label Extension of a Randomized Controlled Trial

I. Reid, G. Gamble, A. Grey, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women.

I. Reid, R. Ames, G. Gamble, 2006, Bone.

The impact of dietary calcium intake and vitamin D status on the effects of zoledronate

I. Reid, G. Gamble, A. Grey, 2012, Osteoporosis International.

Bone metabolism during long-term treatment with imatinib

G. Gamble, P. Browett, D. Wattie, 2013, Leukemia & lymphoma.

The skeletal effects of the tyrosine kinase inhibitor nilotinib.

G. Gamble, J. Cornish, K. Callon, 2011, Bone.

Decreased bone turnover despite persistent secondary hyperparathyroidism during prolonged treatment with imatinib.

G. Gamble, P. Ebeling, K. Callon, 2009, The Journal of clinical endocrinology and metabolism.

Imatinib Promotes Osteoblast Differentiation by Inhibiting PDGFR Signaling and Inhibits Osteoclastogenesis by Both Direct and Stromal Cell‐Dependent Mechanisms

J. Cornish, K. Callon, M. Watson, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Age‐, gender‐, and weight‐related effects on levels of 25‐hydroxyvitamin D are not mediated by vitamin D binding protein

I. Reid, R. Ames, G. Gamble, 2007, Clinical endocrinology.

Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2000, The American journal of medicine.

Development of a radiographic scoring system for new bone formation in gout

N. Dalbeth, L. Stamp, A. Horne, 2021, Arthritis Research & Therapy.

Acute effects of calcium supplements on blood pressure: randomised, crossover trial in postmenopausal women

I. Reid, G. Gamble, A. Horne, 2016, Osteoporosis International.

Randomized controlled trial of calcium in healthy older women.

I. Reid, R. Ames, G. Gamble, 2006, The American journal of medicine.

Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women.

I. Reid, G. Gamble, A. Horne, 2014, The British journal of nutrition.

The Auckland calcium study: 5-year post-trial follow-up

I. Reid, G. Gamble, A. Grey, 2013, Osteoporosis International.

Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men.

I. Reid, R. Ames, G. Gamble, 2008, Archives of internal medicine.

High-dose oral vitamin D3 supplementation in the elderly

I. Reid, G. Gamble, C. Bacon, 2009, Osteoporosis International.

Greater insulin response to acute fructose ingestion among Māori and Pacific people compared to European people living in Aotearoa New Zealand

T. Merriman, G. Gamble, N. Dalbeth, 2019, Internal medicine journal.

Decreased bone density in men on methadone maintenance therapy.

I. Reid, G. Gamble, A. Grey, 2011, Addiction.

Prolonged antiresorptive activity of zoledronate: A randomized, controlled trial

I. Reid, G. Gamble, A. Grey, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency.

I. Reid, R. Ames, G. Gamble, 2003, The New Zealand medical journal.

Elevated Urate Levels Do Not Alter Bone Turnover Markers: Randomized Controlled Trial of Inosine Supplementation in Postmenopausal Women

T. Merriman, I. Reid, G. Gamble, 2021, Arthritis & rheumatology.

Effect of body mass index on serum urate and renal uric acid handling responses to an oral inosine load: experimental intervention study in healthy volunteers

T. Merriman, G. Gamble, N. Dalbeth, 2020, Arthritis Research & Therapy.

Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.

T. Cundy, J. Lucas, A. Horne, 2005, Rheumatology.

Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial.

I. Reid, G. Gamble, A. Grey, 2012, The Journal of clinical endocrinology and metabolism.

Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2002, The American journal of medicine.

Nitrates Do Not Affect Bone Density or Bone Turnover in Postmenopausal Women: A Randomized Controlled Trial

I. Reid, G. Gamble, A. Grey, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

K. Petrie, W. Taylor, N. Dalbeth, 2012, BMC Musculoskeletal Disorders.

Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout

T. Merriman, G. Gamble, N. Dalbeth, 2015, Arthritis Research & Therapy.

Vitamin D insufficiency and health outcomes over 5 y in older women.

I. Reid, R. Ames, G. Gamble, 2010, The American journal of clinical nutrition.

Vitamin D insufficiency and health outcomes over 5 y in older women 1 – 3

I. Reid, R. Ames, G. Gamble, 2009 .

Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trial

I. Reid, G. Gamble, A. Grey, 2017, Canadian Medical Association Journal.

Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men.

I. Reid, G. Gamble, A. Grey, 2012, The Journal of clinical endocrinology and metabolism.

Longitudinal changes in bone mineral density, bone mineral content and bone area at the lumbar spine and hip in postmenopausal women, and the influence of abdominal aortic calcification

I. Reid, G. Gamble, A. Horne, 2018, Bone reports.

Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.

I. Reid, G. Gamble, A. Grey, 2005, The Journal of clinical endocrinology and metabolism.

Determinants of vitamin D status in older women living in a subtropical climate

I. Reid, R. Ames, G. Gamble, 2005, Osteoporosis International.

Dietary calcium intake and bone loss over 6 years in osteopenic postmenopausal women.

I. Reid, G. Gamble, A. Horne, 2019, The Journal of clinical endocrinology and metabolism.

Hormone replacement therapy causes a respiratory alkalosis in normal postmenopausal women.

I. Reid, A. Grey, M. Evans, 1999, The Journal of clinical endocrinology and metabolism.

Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2010, The American journal of clinical nutrition.

Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2005, The Journal of clinical endocrinology and metabolism.

Bone density in healthy men after cessation of calcium supplements: 20-month follow-up of a randomized controlled trial

I. Reid, R. Ames, G. Gamble, 2014, Osteoporosis International.

Acute effects of calcium citrate with or without a meal, calcium-fortified juice and a dairy product meal on serum calcium and phosphate: a randomised cross-over trial.

I. Reid, G. Gamble, A. Horne, 2015, The British journal of nutrition.

Urate crystal deposition and bone erosion in gout: ‘inside-out’ or ‘outside-in’? A dual-energy computed tomography study

G. Gamble, N. Dalbeth, L. Stamp, 2016, Arthritis Research & Therapy.

Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study

G. Gamble, N. Dalbeth, A. Horne, 2014, Annals of the rheumatic diseases.

Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial

I. Reid, C. McGhee, D. Patel, 2015, Osteoporosis International.

Zoledronate Slows Weight Loss and Maintains Fat Mass in Osteopenic Older Women: Secondary Analysis of a Randomized Controlled Trial

I. Reid, G. Gamble, A. Horne, 2020, Calcified Tissue International.

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial.

I. Reid, G. Gamble, A. Grey, 2007, The Journal of clinical endocrinology and metabolism.

Determinants of vitamin D status in older men living in a subtropical climate

I. Reid, R. Ames, G. Gamble, 2006, Osteoporosis International.

The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women

I. Reid, R. Ames, G. Gamble, 2007, Osteoporosis International.

Intensive Serum Urate Lowering With Oral Urate‐Lowering Therapy for Erosive Gout: A Randomized Double‐Blind Controlled Trial

G. Gamble, N. Dalbeth, L. Stamp, 2021, Arthritis & rheumatology.

Path Analysis Identifies Receptor Activator of Nuclear Factor-κB Ligand, Osteoprotegerin, and Sclerostin as Potential Mediators of the Tophus-bone Erosion Relationship in Gout

I. Reid, G. Gamble, J. Cornish, 2016, The Journal of Rheumatology.

Erosion Relationship in Gout Osteoprotegerin , and Sclerostin as Potential Mediators of the Tophus-bone B Ligand , κ Path Analysis Identifies Receptor Activator of Nuclear Factor-Dalbeth

I. Reid, G. Gamble, J. Cornish, 2015 .

Bone mineral density is not reduced in HIV‐infected Caucasian men treated with highly active antiretroviral therapy

I. Reid, G. Gamble, A. Grey, 2006, Clinical endocrinology.

Randomised controlled trial of vitamin D supplementation in sarcoidosis

I. Reid, G. Gamble, A. Grey, 2013, BMJ Open.

Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study

G. Gamble, N. Dalbeth, L. Stamp, 2015, Annals of the rheumatic diseases.

Effect of monthly high‐dose vitamin D on bone density in community‐dwelling older adults substudy of a randomized controlled trial

C. Camargo, I. Reid, C. Camargo, 2017, Journal of internal medicine.

Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone

S. Lewis, M. Boers, G. Murray, 2019, BMJ Open.

Zoledronate in the prevention of Paget(cid:146)s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1 mediated Paget(cid:146)s disease of bone

S. Lewis, M. Boers, S. Ralston, 2019 .

Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability

K. Petrie, W. Taylor, N. Dalbeth, 2011, Arthritis care & research.

Denosumab did not improve computerized tomography erosion scores when added to intensive urate-lowering therapy in gout: Results from a pilot randomized controlled trial.

K. Saag, N. Dalbeth, A. Mudano, 2021, Seminars in arthritis and rheumatism.

Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension study

N. Dalbeth, M. Barclay, C. Frampton, 2017, Annals of the rheumatic diseases.

A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout

N. Dalbeth, M. Barclay, C. Frampton, 2017, Annals of the rheumatic diseases.

Relationship of bone erosion with the urate and soft tissue components of the tophus in gout: a dual energy computed tomography study

G. Gamble, N. Dalbeth, A. Horne, 2017, Rheumatology.

The effect of age on the microarchitecture and profile of gene expression in femoral head and neck bone from patients with osteoarthritis

Jacob T. Munro, I. Reid, G. Gamble, 2020, Bone reports.

Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial

I. Reid, G. Gamble, J. Cornish, 2010, Annals of the rheumatic diseases.

Effects of Hormone Replacement Therapy on Bone Mineral Density in Postmenopausal Women With Primary Hyperparathyroidism

I. Reid, A. Grey, M. Evans, 2016 .

Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.

I. Reid, A. Grey, M. Evans, 2000, Archives of internal medicine.

Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up

I. Reid, A. Horne, B. Mihov, 2019, Calcified Tissue International.

Bone Loss After Denosumab: Only Partial Protection with Zoledronate

I. Reid, G. Gamble, A. Horne, 2017, Calcified Tissue International.

Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.

I. Reid, G. Gamble, A. Grey, 2008, The New Zealand medical journal.

Testosterone Levels Following Decreases in Serum Osteocalcin

I. Reid, A. Grey, M. Bolland, 2013, Calcified Tissue International.

Bone mineral density remains stable in HAART‐treated HIV‐infected men over 2 years

I. Reid, G. Gamble, A. Grey, 2007, Clinical endocrinology.

Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates

I. Reid, A. Horne, B. Mihov, 2018, Calcified Tissue International.

Illness Perceptions and Mortality in Patients With Gout: A Prospective Observational Study

K. Petrie, W. Taylor, N. Dalbeth, 2017, Arthritis care & research.

3-D bone models to improve treatment initiation among patients with osteoporosis: A randomised controlled pilot trial

K. Petrie, K. Faasse, A. Grey, 2016, Psychology & health.

Illness Perceptions Predict Mortality in Patients with Gout: A Prospective Observational Study

K. Petrie, W. Taylor, N. Dalbeth, 2016 .

Ten years of very infrequent zoledronate therapy in older women: an open-label extension of a randomized trial.

I. Reid, G. Gamble, A. Grey, 2020, The Journal of clinical endocrinology and metabolism.

Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women

I. Reid, G. Gamble, A. Horne, 2015, British Journal of Nutrition.

Stable bone mineral density over 6 years in HIV‐infected men treated with highly active antiretroviral therapy (HAART)

I. Reid, G. Gamble, A. Grey, 2012, Clinical endocrinology.

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial.

I. Reid, G. Gamble, A. Grey, 2007, The Journal of clinical endocrinology and metabolism.

Osteomalacia in an HIV-infected man receiving rifabutin, a cytochrome P450 enzyme inducer: a case report

A. Grey, M. Bolland, Mark G Thomas, 2008, Annals of Clinical Microbiology and Antimicrobials.

Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

P. Barber, R. Doughty, I. Reid, 2008, BMJ : British Medical Journal.

Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial.

I. Reid, G. Gamble, A. Grey, 2007, The Journal of clinical endocrinology and metabolism.

Zoledronate Reduces Height Loss Independently of Vertebral Fracture Occurrence in a Randomized Trial in Osteopenic Older Women

I. Reid, M. Bolland, A. Horne, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Anti‐fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial

I. Reid, G. Gamble, M. Bolland, 2019, Journal of internal medicine.

Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial

I. Reid, G. Gamble, W. C. O'Neill, 2016, Osteoporosis International.

Effects of elevated serum urate on cardiometabolic and kidney function markers in a randomised clinical trial of inosine supplementation

T. Merriman, I. Reid, D. Mount, 2022, Scientific reports.

Development of a radiographic scoring system for new bone formation in gout

N. Dalbeth, L. Stamp, A. Horne, 2021, Arthritis Research & Therapy.

Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual‐Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial

N. Dalbeth, C. Frampton, L. Stamp, 2019, Arthritis & rheumatology.

Factors associated with change in radiographic damage scores in gout: a prospective observational study

G. Gamble, W. Taylor, N. Dalbeth, 2016, Annals of the rheumatic diseases.

Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial

I. Reid, G. Gamble, N. Dalbeth, 2014, Annals of the rheumatic diseases.

Tendon involvement in the feet of patients with gout: a dual-energy CT study

N. Dalbeth, A. Horne, F. McQueen, 2013, Annals of the rheumatic diseases.

Which Attributes Are Most and Least Important to Patients When Considering Gout Flare Burden Over Time? A Best-worst Scaling Choice Study

G. Hosie, W. Taylor, N. Dalbeth, 2021, The Journal of Rheumatology.

Does degree of baldness influence vitamin D status?

I. Reid, R. Ames, A. Grey, 2008, The Medical journal of Australia.

Molecular characterisation of osteoblasts from bone obtained from people of Polynesian and European ancestry undergoing joint replacement surgery

I. Reid, G. Gamble, J. Cornish, 2021, Scientific Reports.

A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.

I. Reid, R. Ames, G. Gamble, 2003, The Journal of clinical endocrinology and metabolism.

Effects of Zoledronate on Cancer, Cardiac Events, and Mortality in Osteopenic Older Women

I. Reid, G. Gamble, A. Horne, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fracture Prevention with Zoledronate in Older Women with Osteopenia

I. Reid, G. Gamble, M. Bolland, 2018, The New England journal of medicine.

Effect of oral zoledronate administration on bone turnover in older women

I. Reid, Mengyang Liu, Jingyuan Wen, 2022, British journal of clinical pharmacology.

Bone formation markers in adults with mild osteogenesis imperfecta.

G. Gamble, T. Cundy, M. Bolland, 2007, Clinical chemistry.

Lack of change in urate deposition by dual-energy computed tomography among clinically stable patients with long-standing tophaceous gout: a prospective longitudinal study

G. Gamble, N. Dalbeth, A. Horne, 2013, Arthritis Research & Therapy.

Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort

S. Lewis, S. Ralston, M. Brandi, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Characteristics of early Paget's disease in SQSTMI mutation carriers: baseline analysis of the ZIPP study cohort. Bone and Mineral Research.

S. Lewis, S. Ralston, M. Brandi, 2020 .

The incidence of acute anterior uveitis after intravenous zoledronate.

I. Reid, C. McGhee, D. Patel, 2013, Ophthalmology.

The Effects of Re-challenge in Patients with a History of Acute Anterior Uveitis Following Intravenous Zoledronate

I. Reid, C. McGhee, D. Patel, 2015, Calcified Tissue International.

Bone density is normal and does not change over 2 years in sarcoidosis

I. Reid, G. Gamble, A. Grey, 2015, Osteoporosis International.

The effect of calcium supplementation on serum urate: analysis of a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2008, Rheumatology.

Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial

I. Reid, R. Ames, G. Gamble, 2012, Annals of the rheumatic diseases.

Evaluation of the FRAX and Garvan fracture risk calculators in older women

Mark J Bolland, I. Reid, R. Ames, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial.

I. Reid, G. Gamble, A. Grey, 2014, European journal of endocrinology.

Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures.

I. Reid, R. Ames, G. Gamble, 2002, Archives of internal medicine.

The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion

T. Merriman, G. Gamble, N. Dalbeth, 2020, Nature Communications.

Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate‐Lowering Response—In Search of a Minimum Effective Oxypurinol Concentration

T. Merriman, N. Dalbeth, M. Barclay, 2019, Clinical and translational science.

The challenges of gout flare reporting: mapping flares during a randomized controlled trial

G. Gamble, W. Taylor, N. Dalbeth, 2019, BMC Rheumatology.

The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency.

I. Reid, R. Ames, G. Gamble, 2007, The American journal of clinical nutrition.

The experience and impact of gout in Māori and Pacific people: a prospective observational study

K. Petrie, W. Taylor, N. Dalbeth, 2013, Clinical Rheumatology.

Duration of Antiresorptive Effects of Low‐Dose Zoledronate in Osteopenic Postmenopausal Women: A Randomized, Placebo‐Controlled Trial

I. Reid, G. Gamble, A. Grey, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Randomised trial assessing the impact of framing of fracture risk and osteoporosis treatment benefits in patients undergoing bone densitometry

G. Gamble, K. Petrie, A. Grey, 2017, BMJ Open.

Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2007, The Journal of clinical endocrinology and metabolism.

Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial

I. Reid, G. Gamble, A. Horne, 2017, Osteoporosis International.

The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women.

I. Reid, G. Gamble, A. Grey, 2009, The Journal of clinical endocrinology and metabolism.

Predictors of Fracture in Older Women With Osteopenic Hip Bone Mineral Density Treated With Zoledronate

I. Reid, G. Gamble, M. Bolland, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Dietary calcium intake and rate of bone loss in men

I. Reid, G. Gamble, A. Horne, 2017, British Journal of Nutrition.

Toward Development of a Tophus Impact Questionnaire: A Qualitative Study Exploring the Experience of People With Tophaceous Gout

W. Taylor, N. Dalbeth, A. Horne, 2014, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Low-dose fluoride in postmenopausal women: a randomized controlled trial.

I. Reid, G. Gamble, K. Callon, 2013, The Journal of clinical endocrinology and metabolism.

Effect of a Three‐Day Course of Dexamethasone on Acute Phase Response Following Treatment With Zoledronate: A Randomized Controlled Trial

I. Reid, A. Horne, E. Billington, 2023, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of Intravenous Zoledronate on Bone Turnover and Bone Density Persist for at Least 11 Years in HIV‐Infected Men

I. Reid, G. Gamble, A. Grey, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effect of Zoledronate on Lower Respiratory Infections in Older Women: Secondary Analysis of a Randomized Controlled Trial

I. Reid, G. Gamble, A. Horne, 2021, Calcified Tissue International.

Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.

I. Reid, G. Gamble, A. Grey, 2012, Bone.

Effects of Intravenous Zoledronate on Bone Turnover and BMD Persist for at Least 24 Months

I. Reid, K. Callon, A. Grey, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction

I. Reid, R. Ames, G. Gamble, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trial.

G. Gamble, A. Grey, M. Bolland, 2012, European journal of endocrinology.

Relationships between vascular calcification, calcium metabolism, bone density, and fractures

I. Reid, R. Ames, G. Gamble, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone Loss After Denosumab: Only Partial Protection with Zoledronate

I. Reid, G. Gamble, A. Horne, 2017, Calcified Tissue International.

Testosterone Levels Following Decreases in Serum Osteocalcin

I. Reid, A. Grey, M. Bolland, 2013, Calcified Tissue International.

Calcium supplementation does not affect CRP levels in postmenopausal women – a randomized controlled trial

I. Reid, R. Ames, G. Gamble, 2006, Osteoporosis International.

Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy

I. Reid, G. Gamble, A. Grey, 2019, Calcified Tissue International.

Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors

G. Gamble, K. Petrie, A. Grey, 2012, Osteoporosis International.

Clinical and genetic features of diuretic-associated gout: a case-control study.

T. Merriman, N. Dalbeth, A. Phipps-Green, 2016, Rheumatology.

Radiographic damage scores predict grip strength in patients with tophaceous gout.

N. Dalbeth, A. Horne, A. Doyle, 2019, Rheumatology.

Gout Flare Severity From the Patient Perspective: A Qualitative Interview Study

W. Taylor, M. Gott, N. Dalbeth, 2020, Arthritis care & research.

Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial

N. Dalbeth, M. Barclay, C. Frampton, 2018, Rheumatology.

No Reduction in Circulating Preosteoclasts 18 Months after Treatment with Zoledronate: Analysis from a Randomized Placebo Controlled Trial

I. Reid, J. Cornish, N. Dalbeth, 2012, Calcified Tissue International.

The Patient Experience of Gout Remission: A Qualitative Study

N. Dalbeth, A. Horne, S. Stewart, 2023, ACR open rheumatology.

Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load

T. Merriman, G. Gamble, N. Dalbeth, 2013, Annals of the rheumatic diseases.

Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates

I. Reid, A. Horne, B. Mihov, 2018, Calcified Tissue International.

Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up

I. Reid, A. Horne, B. Mihov, 2019, Calcified Tissue International.

How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose

N. Dalbeth, M. Barclay, C. Frampton, 2018, Arthritis Research & Therapy.

Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout

W. Taylor, N. Dalbeth, A. Horne, 2013, BMC Musculoskeletal Disorders.

Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20)

W. Taylor, R. Siegert, N. Dalbeth, 2014, Annals of the rheumatic diseases.

Assessment of Tophus Size: A Comparison Between Physical Measurement Methods and Dual-Energy Computed Tomography Scanning

N. Dalbeth, A. Horne, M. House, 2012, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool

T. Merriman, N. Dalbeth, M. Barclay, 2018, British journal of clinical pharmacology.

Influence of genetic variants on renal uric acid handling in response to frusemide: an acute intervention study

R. Doughty, T. Merriman, G. Gamble, 2017, RMD Open.

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge

T. Merriman, G. Gamble, N. Dalbeth, 2014, Arthritis Research & Therapy.

Population-specific effects of SLC17A1 genotype on serum urate concentrations and renal excretion of uric acid during a fructose load

T. Merriman, G. Gamble, N. Dalbeth, 2013, Annals of the rheumatic diseases.

Complementary and Alternative Medicine Use in Patients With Gout: A Longitudinal Observational Study

K. Petrie, W. Taylor, N. Dalbeth, 2014, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Predictors of activity limitation in people with gout: a prospective study

W. Taylor, K. Rome, N. Dalbeth, 2018, Clinical Rheumatology.

The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial

N. Dalbeth, M. Barclay, C. Frampton, 2017, Arthritis Research & Therapy.

Predictors of Mortality in People with Recent-onset Gout: A Prospective Observational Study

W. Taylor, N. Dalbeth, G. Gamble, 2017, The Journal of Rheumatology.

Zoledronate Slows Weight Loss and Maintains Fat Mass in Osteopenic Older Women: Secondary Analysis of a Randomized Controlled Trial

I. Reid, G. Gamble, A. Horne, 2020, Calcified Tissue International.

Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial

N. Dalbeth, L. Stamp, C. Frampton, 2023, Annals of the rheumatic diseases.

A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout

N. Dalbeth, M. Barclay, C. Frampton, 2017, Annals of the rheumatic diseases.

Relationship Between Changes in Serum Urate and Bone Mineral Density During Treatment with Thiazide Diuretics: Secondary Analysis from a Randomized Controlled Trial

I. Reid, G. Gamble, N. Dalbeth, 2016, Calcified Tissue International.

Vitamin D insufficiency and health outcomes over 5 y in older women.

I. Reid, R. Ames, G. Gamble, 2010, The American journal of clinical nutrition.

Relationships between vascular calcification, calcium metabolism, bone density, and fractures

I. Reid, R. Ames, G. Gamble, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Does degree of baldness influence vitamin D status?

I. Reid, R. Ames, A. Grey, 2008, The Medical journal of Australia.

Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial.

I. Reid, R. Ames, G. Gamble, 2005, The Journal of clinical endocrinology and metabolism.

No Effect of NSAID Use on Efficacy of Zoledronate: A Post Hoc Analysis of a Randomized Trial in Osteopenic Older Women

I. Reid, A. Horne, S. Bastin, 2023, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men.

I. Reid, R. Ames, G. Gamble, 2008, Archives of internal medicine.

Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

R. Doughty, I. Reid, R. Ames, 2008, BMJ : British Medical Journal.